Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
4.840
+0.090 (1.89%)
Nov 5, 2024, 4:00 PM EST - Market closed

Elicio Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-38.67-35.2-28.21-26.4-15.71-12.26
Depreciation & Amortization
1.141.171.060.250.190.11
Loss (Gain) From Sale of Assets
0.10.110--0
Stock-Based Compensation
1.351.180.580.620.30.15
Other Operating Activities
-1.710.14.540.720.050.02
Change in Accounts Payable
-3.210.021.130.031.12-0
Change in Other Net Operating Assets
4.86-0.08-1.280.84-2.662.69
Operating Cash Flow
-36.13-32.69-22.18-23.94-16.7-9.29
Capital Expenditures
-0.09-0.07-0.65-0.53-0.2-0.49
Sale of Property, Plant & Equipment
00.03----
Investing Cash Flow
-0.08-0.03-0.65-0.53-0.2-0.49
Short-Term Debt Issued
---14.68--
Long-Term Debt Issued
-10----
Total Debt Issued
-10-14.68--
Net Debt Issued (Repaid)
-10-14.68--
Issuance of Common Stock
18.47.130.080.210.25-
Repurchase of Common Stock
--0.15----
Other Financing Activities
021.64--0.44--0.89
Financing Cash Flow
18.438.6121.219.3925.066.29
Net Cash Flow
-17.855.89-1.63-5.078.16-3.49
Free Cash Flow
-36.22-32.76-22.83-24.46-16.9-9.78
Free Cash Flow Per Share
-3.76-6.48-72.26-1.60-1.58-2.48
Levered Free Cash Flow
-22.08-16.93-20.49-12.51-8.02-
Unlevered Free Cash Flow
-22.03-16.27-18.24-11.96-8.02-
Change in Net Working Capital
-1.4-3.794.39-3.62-1.51-
Source: S&P Capital IQ. Standard template. Financial Sources.